Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790068 | Urologic Oncology: Seminars and Original Investigations | 2018 | 8 Pages |
Abstract
PSR is a novel prognostic factor in patients with aUC receiving first-line platinum-based chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hiroshi M.D., Madoka M.D., Yasukazu M.D., Ph.D., Kazumasa M.D., Kosuke M.D., Ph.D., Hiroaki M.D., Masaya M.D., Ph.D., Ken-ichi M.D., Ph.D., Yasuhisa M.D., Ph.D., Fumitaka M.D., Ph.D.,